They seem to like the stock... they now own 14.11% of the company... think about it, a US fund manager buying even more shares in a small, loss making aussie biotech.
Seems pretty suspicious to me.
NRT Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
